108 results
Page 4 of 6
8-K
EX-99.1
l1bv9m9vum9pg
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
irt299
31 Oct 19
Other Events
10:10am
8-K
EX-99.2
a1poyx2k09
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
7p4u4t355tx 6dblh7
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
ml8h4l xxg1n433xvk49
20 May 19
Other Events
8:52am
8-K
EX-99.1
9r30u5s zm
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
bdu21w83p7d99 e4im
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
xtexw7txqxv0o618xlwm
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.2
rpkp4 vmtcq4c
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
wo9pdl5p613bbzhpj
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
r7kl 1mvkyr9n
7 Jan 19
Other Events
7:01am
8-K
EX-99.1
naxbri5445
10 Dec 18
Other Events
2:07pm
8-K
EX-99.1
64o9hnnj42u2mfe4i4m
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.2
qjhsof3
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
d4pwa2kvye9cc8rh
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am